Lyell Immunopharma, Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lyell Immunopharma, Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Lyell Immunopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was -34.6 %, a 39% decline year-over-year.
  • Lyell Immunopharma, Inc. annual Return On Equity for 2023 was -32.7 %, a 51.7% decline from 2022.
  • Lyell Immunopharma, Inc. annual Return On Equity for 2022 was -21.5 %, a 44% increase from 2021.
  • Lyell Immunopharma, Inc. annual Return On Equity for 2021 was -38.4 %, a 145% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -32.7 -11.1 -51.7% Jan 1, 2023 Dec 31, 2023
2022 -21.5 +16.9 +44% Jan 1, 2022 Dec 31, 2022
2021 -38.4 -125 -145% Jan 1, 2021 Dec 31, 2021
2020 86.1 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.